Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A

about

Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A

Item

http://www.wikidata.org/entity/Q42376733

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Review of recombinant anti-hae ...... ts with acquired haemophilia A

@en

Review of recombinant anti-hae ...... ts with acquired haemophilia A

@nl

type

Item

label

Review of recombinant anti-hae ...... ts with acquired haemophilia A

@en

Review of recombinant anti-hae ...... ts with acquired haemophilia A

@nl

prefLabel

Review of recombinant anti-hae ...... ts with acquired haemophilia A

@en

Review of recombinant anti-hae ...... ts with acquired haemophilia A

@nl

P1476

Review of recombinant anti-hae ...... ts with acquired haemophilia A

@en

P2093

Anja Drebes

http://www.w3.org/2001/XMLSchema#string

Anne Riddell

http://www.w3.org/2001/XMLSchema#string

Emma Fosbury

http://www.w3.org/2001/XMLSchema#string

Pratima Chowdary

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A.

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Porcine factor VIII: current status and future developments.

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Acquired hemophilia A: a concise review.

Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal.

Recombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients.

HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD.

Porcine recombinant factor VIII (Obizur; OBI-1; BAX801): product characteristics and preclinical profile.

Lower doses of recombinant porcine factor VIII maintain excellent haemostatic efficacy.

P304

263-272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2040620717720861

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29051804

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

hemophilia A

Coagulation factor VIII

P932

5639975

http://www.w3.org/2001/XMLSchema#string